Aprepitant: Medgend

Aprepitant FDA Approved Drugs

APREPITANT [Aprepitant^{C₂₃H₂₁F₇N₄O₃}]

125mg (oral capsule)

40mg (oral capsule)

80mg (oral capsule)

Sandoz^{Sep 24, 2012}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

EMEND [Aprepitant^{C₂₃H₂₁F₇N₄O₃}]

125mg (oral capsule)

125mg/kit (oral for suspension)

40mg (oral capsule)

80mg (oral capsule)

Merck^{Mar 26, 2003}
Msd Merck Co^{Dec 17, 2015}

efficacy
2.0 (1)

side effects
4.0 (1)

danger
0.0 (0)

EMEND [Fosaprepitant Dimeglumine^{C₂₃H₂₂F₇N₄O₆P2C₇H₁₇NO₅}]

eq 150mg base/vial (intravenous powder)

Merck And Co Inc^{Nov 12, 2010}

efficacy
4.0 (1)

side effects
0.0 (0)

danger
0.0 (0)

FOSAPREPITANT DIMEGLUMINE [Fosaprepitant Dimeglumine^{C₂₃H₂₂F₇N₄O₆P2C₇H₁₇NO₅}]

eq 150mg base/vial (intravenous powder)

Fresenius Kabi Usa^{Jun 9, 2016}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.